Omnivore plans to invest in life sciences

Omnivore is also planning a couple of exits this year from its second fund and is in talks to create an exit strategy

- Rwit Ghosh

Impact investment firm Omnivore is considering investments in animal health, bioinformatics, precision fermentation, and another deal in material science, a top official said.

The firm plans to close between four and six deals this year, of which two will be in the life sciences space. "I would love to do a life sciences deal related to animal science. It's a sector ripe for disruption and has great challenges. The sector has strong economics and good margins," Mark Kahn, managing partner at Omnivore, said. The firm is also planning a couple of exits this year from its second fund. Omnivore is currently in talks with some of the founders of its portfolio companies and bankers about creating an exit strategy.